Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Ko, Sheung Fat ^a   Yip, Hon Kan ^a   Zhen, Yen Yi ^a   Lee, Chen Chang ^a   Lee, Chia Chang ^a   Huang, Chung Cheng ^a   Ng, Shu Hang ^a   Lin, Jui Wei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD63 ANTIGEN; CD8ALPHA ANTIGEN; CONTRAST MEDIUM; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER GRADING; CANCER INHIBITION; CELL THERAPY; CELLULAR DISTRIBUTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; ELECTRON MICROSCOPY; EXOSOME; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TREATMENT RESPONSE; TUMOR VOLUME; WESTERN BLOTTING;

RATTUS;

EID: 84939796146     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/853506     Document Type: Article

References (34)

1. A.Forner, J.M. Llovet, and J. Bruix, "Hepatocellular carcinoma," The Lancet, vol. 379, no. 9822, pp. 1245-1255, 2012.
2. J. Huang, L. Yan, Z. Cheng et al., "Arandomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to theMilan criteria," Annals of Surgery, vol. 252, no. 6, pp. 903-912, 2010.
3. P.-A.Clavien,M. Lesurtel, P. M. Bossuyt, G. J. Gores, B. Langer, and A. Perrier, "Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report," The Lancet Oncology, vol. 13, no. 1, pp. e11-e22, 2012.
4. W. Wang, J. Shi, and W.-F. Xie, "Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis," Liver International, vol. 30, no. 5, pp. 741-749, 2010.
5. R. Salem, R. J. Lewandowski, M. F. Mulcahy et al., "Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes," Gastroenterology, vol. 138, no. 1, pp. 52-64, 2010.
6. A.-L. Cheng, Y.-K. Kang, Z. Chen et al., "Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, doubleblind, placebo-controlled trial,"TheLancetOncology, vol. 10,no. 1, pp. 25-34, 2009.
7. H.-G. Zhang, X. Zhuang, D. Sun, Y. Liu, X. Xiang, and W. E. Grizzle, "Exosomes and immune surveillance of neoplastic lesions: a review," Biotechnic and Histochemistry, vol. 87, no. 3, pp. 161-168, 2012.
8. M. Record, C. Subra, S. Silvente-Poirot, and M. Poirot, "Exosomes as intercellular signalosomes and pharmacological effectors," Biochemical Pharmacology, vol. 81, no. 10, pp. 1171-1182, 2011.
9. V. Racanelli and B. Rehermann, "The liver as an immunological organ," Hepatology, vol. 43, no. 2, pp. S54-S62, 2006.
10. B. Gao,W.-I. Jeong, and Z. Tian, "Liver: an organ with predominant innate immunity," Hepatology, vol. 47, no. 2, pp. 729-736, 2008.
11. L. Qiao, Z. Xu, T. Zhao et al., "Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model," Cell Research, vol. 18, no. 4, pp. 500-507, 2008.
12. T. Li, B. Song, X. Du, Z. Wei, and T. Huo, "Effect of bonemarrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study," European Journal of Medical Research, vol. 18, no. 1, article 34, 2013.
13. R. Gillmore, S. Stuart, A. Kirkwood et al., "EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization," Journal of Hepatology, vol. 55, no. 6, pp. 1309-1316, 2011.
14. J. H. Shim, H. C. Lee, S. O. Kim et al., "Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models," Radiology, vol. 262, no. 2, pp. 708-718, 2012.
15. B. Taouli and D.-M. Koh, "Diffusion-weighted MR imaging of the liver," Radiology, vol. 254, no. 1, pp. 47-66, 2010.
16. S. Dong, X.-D. Ye, Z. Yuan, L.-C. Xu, and X.-S. Xiao, "Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization," European Journal of Radiology, vol. 81, no. 3, pp. 472-477, 2012.
17. V. Vandecaveye, K.Michielsen, F. De Keyzer et al., "Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome," Radiology, vol. 270, no. 3, pp. 747-757, 2014.
18. S. H. Heo, Y. Y. Jeong, S. S. Shin et al., "Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor," Korean Journal of Radiology, vol. 11, no. 3, pp. 295-303, 2010.
19. A. Muhi, T. Ichikawa, U. Motosugi et al., "High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma," Journal of Magnetic Resonance Imaging, vol. 30, no. 5, pp. 1005-1011, 2009.
20. Y. T. Chen, C. K. Sun, Y. C. Lin et al., "Adipose-derived mesenchymal stem cell protects kidneys againstischemiareperfusion injury through suppressing oxidative stress and inflammatoryreaction," Journal of TranslationalMedicine, vol. 9, article 51, 2011.
21. H. A. Edmondson and P. E. Steiner, "Primary carcinoma of the liver: a study of 100 cases among 48,900," Cancer, vol. 7, no. 3, pp. 462-503, 1954.
22. H. Ishikawa, K. Nakao, K. Matsumoto et al., "Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma," Gut, vol. 53, no. 6, pp. 884-889, 2004.
23. M.Barone,M. P. Scavo, E.Maiorano,A.DiLeo, andA. Francavilla, "Bonemarrow-derived stemcells and hepatocarcinogenesis in hepatitis B virus transgenic mice," Digestive and LiverDisease, vol. 46, no. 3, pp. 243-250, 2014.
24. A. Facciorusso, M. Antonino, V. del Prete, V. Neve, M. P. Scavo, andM. Barone, "Are hematopoietic stemcells involved in hepatocarcinogenesis?" Hepatobiliary Surgery and Nutrition, vol. 3, no. 4, pp. 199-206, 2014.
25. T. Ishikawa, A. Banas, K. Hagiwara, H. Iwaguro, and T. Ochiya, "Stem cells for hepatic regeneration: the role of adipose tissue derived mesenchymal stem cells," Current Stem Cell Research andTherapy, vol. 5, no. 2, pp. 182-189, 2010.
26. D. J. Katzmann, G. Odorizzi, and S. D. Emr, "Receptor downregulation and multivesicular-body sorting," Nature Reviews Molecular Cell Biology, vol. 3, no. 12, pp. 893-905, 2002.
27. H.-H. Chan, T.-H. Chu, H.-F. Chien et al., "Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation," BMC Gastroenterology, vol. 10, article 83, 2010.
28. J.-Y. Choi, J.-M. Lee, and C. B. Sirlin, "CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects," Radiology, vol. 272, no. 3, pp. 635-654, 2014.
29. H. Sahin, M. Harman, C. Cinar, H. Bozkaya, M. Parildar, and N. Elmas, "Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging," Journal of Vascular and Interventional Radiology, vol. 23, no. 2, pp. 241-247, 2012.
30. L. Gattinoni, Y. Ji, andN. P. Restifo, "Wnt/β-catenin signaling in T-cell immunity and cancer immunotherapy," Clinical Cancer Research, vol. 16, no. 19, pp. 4695-4701, 2010.
31. M. Terabe and J. A. Berzofsky, "Chapter 8 The role of NKT cells in tumor immunity," Advances in Cancer Research, vol. 101, pp. 277-348, 2008.
32. O. Shibolet, R. Alper, L. Zlotogarov et al., "NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells," International Journal of Cancer, vol. 106, no. 2, pp. 236-243, 2003.
33. V. O'Reilly, S. G. Zeng, G. Bricard et al., "Distinct and overlapping effector functions of expanded human CD4+, cd8α+ and CD4-CD8α- invariant natural killer T cells," PLoS ONE, vol. 6, no. 12, Article ID e28648, 2011.
34. Y.-S. Xiao, Q. Gao, X.-N. Xu et al., "Combination of intratumoral invariant natural killer T cells and interferon-gammais associated with prognosis of hepatocellular carcinoma after curativeresection," PLoS ONE, vol. 8, no. 8, Article ID e70345, 2013.